Christine Lovly, MD, PhD, Ingram Associate Professor of Cancer Research, has been named incoming chair of GO2 Foundation's Scientific Leadership Board (SLB).

Henry Henderson III, PhD, and Justin Lo, MD, PhD, are members of the 2020-2021 inaugural class of FDA-AACR Oncology Educational Fellows.

Vanderbilt epidemiologists identified new markers for colorectal cancer risk and characterized a previously unidentified tumor suppressor that regulates overall tumor volume in vivo.

All areas of Tennessee have seen a resurgence in hospitalized COVID-19 patients since early October, but hospitals that draw patients from counties without masking requirements are experiencing much sharper increases, according to a new analysis from researchers at Vanderbilt University Medical Center and Vanderbilt University School of Medicine.

While most of 2020 has been pretty scary, Halloween doesn't have to be, say experts at Monroe Carell Jr. Children's Hospital at Vanderbilt.

Researchers at Vanderbilt University Medical Center played a key role in the development of remdesivir, the first drug approved by the U.S. Food and Drug Administration for the treatment of COVID-19.

Despite a decrease in the volume of cars on the road during the COVID-19 pandemic, the National Highway Traffic Safety Administration (NHTSA) reports that driving patterns and behaviors were riskier, leading to an increase in accident-related fatalities since April 2020.